Biostax Corp. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
Biostax Corp. reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 17.73 million shares for the 12-month period ending 2022-12-31, per its 10-K/A filed 2024-07-05.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2024-07-05
- Biostax Corp. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2022-12-31 was 500.00K shares.
- Biostax Corp. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2022-09-30 was 4.66M shares.
- Biostax Corp. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2022 was 17.73M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2022-12-31 | 500.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-05 | 5.16M shares derived: sum of 2 quarters · filed 2024-07-05 | 17.73M shares 10-K/A · filed 2024-07-05 | |
| 2022-09-30 | 4.66M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 17.23M shares 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 12.56M shares 10-Q · filed 2022-08-24 |